CLOV vs KPTI · rev $1.37B vs rev $145.2M
Clover Health Investments Corp (CLOV) versus Karyopharm Therapeutics Inc (KPTI) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported KPTI revenue for 2024-12-31 was $145.2M. Net income was -$76.4M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. KPTI currently screens at market cap $205.6M.
CLOV currently screens at market cap $1.55B. KPTI currently screens at market cap $205.6M.
Not investment advice. Open the CLOV and KPTI stock pages for the full models.
Not investment advice.